ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
Dow Jones
38.239,66
0,40%
Euro vs US Dollar
1,06965
-0,04%
Bitcoin
63.215,02
-0,82%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. NeoGenomics Inc (NEO)

  7. NeoGenomics Inc (NEO) News

NEO NeoGenomics Inc

14,14
0,29 (2,09%)
26 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
NeoGenomics Inc NEO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,29 2,09% 14,14 22:02:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
13,91 13,68 14,35 14,14 13,85
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.4.202413:05BWNeoGenomics Announces Senior Leadership Promotions
09.4.202413:00BWNeoGenomics to Report First Quarter 2024 Financial Results..
27.3.202413:30BWNeoGenomics Showcases Commitment to Transforming Cancer..
20.3.202412:00BWNeoGenomics Releases Inaugural Environmental, Social, and..
06.3.202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:33EDGAR2Form 144 - Report of proposed sale of securities
01.3.202413:05BWNeoGenomics to Participate in the TD Cowen 44th Annual..
27.2.202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202422:15EDGAR2Form 8-K/A - Current report: [Amend]
20.2.202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20.2.202422:06EDGAR2Form 8-K - Current report
20.2.202422:05BWNeoGenomics Reports Fourth Quarter and Full Year 2023..
20.2.202411:37IHMARKETNEWSMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil..
15.2.202422:26EDGAR2Form 144 - Report of proposed sale of securities
14.2.202416:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09.2.202421:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01.2.202413:05BWNeoGenomics Signs Working with Cancer Pledge in Support of..
30.1.202413:05BWNeoGenomics to Report Fourth Quarter and Full Year 2023..
03.1.202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202413:05BWNeoGenomics to Participate in the 42nd Annual J.P. Morgan..
12.12.202301:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202322:25EDGAR2Form 144 - Report of proposed sale of securities
06.11.202322:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202322:18EDGAR2Form 8-K - Current report
03.10.202323:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202323:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202323:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202323:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202323:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202323:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202323:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.8.202322:49EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202313:03EDGAR2Form 8-K - Current report
01.8.202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.7.202300:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
07.7.202301:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
07.7.202300:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
29.6.202322:21EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

NASDAQ
NEO
NeoGenomics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten